Recombinant IL5 (Mepolizumab Biosimilar) 抗体
This Mammalian Cells 单克隆 anti-IL5 (Mepolizumab Biosimilar) antibody specifically detects IL5 (Mepolizumab Biosimilar) in ELISA. The antibody is reactive with 人 samples.
产品编号 ABIN7487818
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant IL5 (Mepolizumab Biosimilar) 抗体 (ABIN7487818)
抗原
IL5 (Mepolizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This IL5 (Mepolizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Mepolizumab Biosimilar - Anti-IL5 mAb
-
产品特性
- Antibody Type: IgG1-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- IL5 (Mepolizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
SB-240563
Mepolizumab is a fully humanized recombinant IgG1 kappa monoclonal antibody directed against IL-5 produced in Chinese hamster ovary cells. (EGPA) and eosinophilia syndrome (HES). The pathogenesis of eosinophils is complex, but IL-5 is considered a key eosinophilic factor, involved in the differentiation, recruitment, activation and prolonged survival of eosinophils in peripheral tissues. Activated eosinophils further stimulate the inflammatory response, and also induce tissue damage and promote fibrosis, all of which contribute to the multifactorial symptoms of eosinophilic disease. Mepolizumab is used to treat severe asthma. -
CAS-编号
- 196078-29-2
抗原
-
You are here:
